{
  "symbol": "BA-PA",
  "year": 2022,
  "report_type": "YearlyIncomeStatement",
  "items": {
    "Tax Effect Of Unusual Items": 10080000.0,
    "Tax Rate For Calcs": 0.21,
    "Normalized EBITDA": 2267000000.0,
    "Total Unusual Items": 48000000.0,
    "Total Unusual Items Excluding Goodwill": 48000000.0,
    "Net Income From Continuing Operation Net Minority Interest": -2222000000.0,
    "Reconciled Depreciation": 1861000000.0,
    "Reconciled Cost Of Revenue": 70070000000.0,
    "EBITDA": 2315000000.0,
    "EBIT": 454000000.0,
    "Net Interest Income": -2459000000.0,
    "Interest Expense": 2459000000.0,
    "Normalized Income": -2259920000.0,
    "Net Income From Continuing And Discontinued Operation": -2222000000.0,
    "Total Expenses": 78615000000.0,
    "Total Operating Income As Reported": -773000000.0,
    "Diluted NI Availto Com Stockholders": -2222000000.0,
    "Net Income Common Stockholders": -2222000000.0,
    "Net Income": -2222000000.0,
    "Minority Interests": 20000000.0,
    "Net Income Including Noncontrolling Interests": -2242000000.0,
    "Net Income Continuous Operations": -2242000000.0,
    "Tax Provision": 237000000.0,
    "Pretax Income": -2005000000.0,
    "Other Income Expense": 1275000000.0,
    "Other Non Operating Income Expenses": 1227000000.0,
    "Special Income Charges": 2000000.0,
    "Gain On Sale Of Ppe": 2000000.0,
    "Gain On Sale Of Security": 46000000.0,
    "Net Non Operating Interest Income Expense": -2459000000.0,
    "Interest Expense Non Operating": 2459000000.0,
    "Operating Income": -821000000.0,
    "Operating Expense": 8545000000.0,
    "Research And Development": 3377000000.0,
    "Selling General And Administration": 5168000000.0,
    "General And Administrative Expense": 5168000000.0,
    "Other Gand A": 5168000000.0,
    "Gross Profit": 7724000000.0,
    "Cost Of Revenue": 70070000000.0,
    "Total Revenue": 77794000000.0,
    "Operating Revenue": 77794000000.0
  }
}